NDC11 70244003502
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70244-0035-02 | 70244-0035 |
| 70244-0035-2 | 70244-0035 |
| 70244-035-02 | 70244-035 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loteprednol Etabonate | LOTEPREDNOL ETABONATE | Sentiss Pharmaceuticals LLC | f210d817-409f-4e69-b8d0-58883c0b43d3 | 2026-04-17 | Warnings, Adverse reactions | 70244-035-02 70244-035 70244003502 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.